It’s Not Over Yet For Quest Diagnostics, Inc. (NYSE: DGX)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Quest Diagnostics, Inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. The current market capitalization of Quest Diagnostics, Inc. is $15.60B. A total of 1.02 million shares were traded on the day, compared to an average of 903.25K shares.

In the most recent transaction, KUPPUSAMY KARTHIK sold 1,760 shares of DGX for 140.00 per share on Apr 29 ’24. After the transaction, the SVP, Clinical Solutions now owns 13,435 company shares. In a previous transaction on Feb 29 ’24, PREVOZNIK MICHAEL E sold 5,611 shares at 125.88 per share. DGX shares that SVP & General Counsel owns now total 38,478.

Among the insiders who sold shares, Doherty Catherine T. disposed of 1,187 shares on Feb 29 ’24 at a per-share price of $125.88. This resulted in the EVP, Regional Businesses holding 68,412 shares of DGX after the transaction. In another insider transaction, Doherty Catherine T. sold 5,557 shares at $126.57 per share on Feb 28 ’24. Company shares held by the EVP, Regional Businesses now total 69,599.


It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Quest Diagnostics, Inc. pays an annual dividend of $2.88, resulting in a dividend yield of 2.05%, and it has a price to earnings (P/E) ratio of 18.90. DGX’s most recent ex-dividend date was 7/8/2024 when it declared a $0.75 quarterly dividend that was paid in cash on 7/22/2024. Previously, the company paid the dividend on 4/22/2024 with an ex-dividend date of 4/5/2024. The DGX stock dividend was $0.75 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, DGX has a high of $145.62 and a low of $119.59.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.77B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $57.95, while its Total Shareholder’s Equity was $6.56B.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Buy with a score of 3.53.

Most Popular

Related Posts